Renata Annual Report

2021-2022

PABX : 8001450-54

Fax : 880-2-8001446

Email : renata@renata-ltd.com

Website : www.renata-ltd.com

Corporate Headquarters: Plot No. 1, Milk Vita Road, Section-7, Mirpur, Dhaka-1216, Bangladesh

TRANSMITTAL LETTER

The Shareholders

Bangladesh Securities and Exchange Commission

Registrar of Joint Stock Companies & Firms

Dhaka Stock Exchange Ltd.

Sub: Annual Report for the year ended June 30, 2022

Dear Sir/Madam (s)

We are pleased to enclose a copy of our Annual Report and Audited Accounts including a Statement of Financial Position, a Statement of Comprehensive Income, and notes and annexes as needed for the year that ended June 30, 2022. We hope you enjoy reviewing the Report and seeing how Renata has grown as a company over the past year.

Yours sincerely,

Md. Jubayer Alam

Company Secretary

October 22, 2022

RENATA LIMITED

Corporate Headquarters: Plot # 1, Milk Vita Road

Section-7, Mirpur, Dhaka-1216

October 22, 2022

NOTICE

NOTICE is hereby given that the 49th Annual General Meeting of Renata Limited will be held on Saturday, December 17, 2022 at 11.30 am through Digital Platform Link- https://agmbd.live/renata2022 (in pursuance with BSEC Order SEC/SRMRC/04-231/25 dated 08 July 2020) to transact the following business :

AGENDA

Agenda-1: To receive, consider and adopt the Audited Accounts of the Company for the year ended June 30, 2022 together with Reports of the Auditors and the Directors.

Agenda-2: To declare dividend for the year which ended on June 30, 2022 (See note ii).

Agenda-3: To elect Directors, in accordance with the relevant provisions of the Articles of Association of the Company.

Agenda-4: To appoint Auditors for the year 2022-23 and to fix their remuneration.

Agenda-5: To appoint Compliance Auditors for the year 2022-23 and to fix their remuneration.

By Order of the Board

(Md. Jubayer Alam)

Company Secretary

NOTES:

  1. The 'Record Date' (in lieu of Book Closure) is Thursday, November 10, 2022. The Shareowners whose name will appear in the Share Register of the Company and in the Depository Register on that Date will be eligible to attend the meeting and qualify for the Dividend to be declared at the AGM.
  2. The Directors have recommended @ 140% cash dividend for year 2021-2022 and stock dividend (bonus share) @ 7% for the year ended June 30, 2022.
  3. A member entitled to attend and vote at the Annual General Meeting may appoint a proxy to attend and vote on his/her behalf. The Proxy Form, duly completed, must be deposited at the Registered Office of the Company at Plot # 1, Milk Vita Road, Section-7, Mirpur, Dhaka-1216 or sent through e-mail at aunikfarid@renata-ltd.com not later than 48 hours before the time fixed for the Meeting.
  4. Members are requested to notify change of address, if any, to the Company. For BO A/C holders, the same to be rectified through their respective Depository Participants.
  5. In Compliance with the BSEC Notification No.BSEC/CMRRCD/2006-158/208/Admin/81 dated 20 June 2018, Annual Report 2021-2022 will be duly sent in soft copy to the respective shareholders e-mail addresses available in their Beneficial Owner (BO) Accounts maintained with the DP. These will also be available in Company's website: www.renata-ltd.com
  6. Full login/participation process Digital Platform Meeting will also be available in the Company's website: www.renata-ltd.com
  7. For any IT related guidance in this regard Members may contact cell number 01811-415502

TABLE OF

CONTENTS

  • Company Profile
  • Our Values
  • Our Mission and Vision
  • Chairman's Statement

21 Board of Directors

  1. Corporate Governance
  2. Directors' Report
  1. Financial Highlights
  2. Financial Trend
  1. Statement of Value Addition
  2. Corporate Social Responsibility

65 Product Portfolio

Financial Statements of

Renata Limited

81 Auditors' Report

  1. Statement of Financial Position
  2. Statement of Profit or Loss & Other Comprehensive Income
  3. Statement of Changes in Equity
  4. Cash Flow Statement

99 Notes to the Financial Statements

Renata (UK) Limited and

Renata Pharmaceuticals (Ireland) Limited

139 Renata (UK) Limited and

Renata Pharmaceuticals (Ireland) Limited

  1. Corporate Directory
  2. Proxy Form

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Renata Limited published this content on 23 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 November 2022 06:34:03 UTC.